Altimmune, Inc. (ALT) NASDAQ
2.95
-0.065(-2.16%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 318.06M |
| Enterprise Value | 309.98M |
| P/E Ratio | -4.02 |
| PEG Ratio | -0.12 |
| Price/Sales Ratio | 7,219.94 |
| Price/Book Ratio | 1.29 |
| Enterprise/Revenue | 5,504.55 |
| Enterprise/EBITDA | -2.12 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -2,530.03 |
| Operating Margin | -2,692.17 |
Management Effectiveness
| Return On Assets | -0.27 |
| Return On Equity | -0.43 |
Income Statement
| Revenue | 41,000 |
| Revenue/Share | 0 |
| Gross Profit | 41,000 |
| EBITDA | -87.03M |
| Net Income | -88.09M |
| Diluted EPS | -1 |
Balance Sheet
| Total Cash | 331.54M |
| Total Cash/Share | 2.66 |
| Total Debt | 35.85M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 29.56 |
| Book Value Per Share | 2.28 |
Price History
| 52-Week Change | -44.43 |
| 52-Week High | 7.73 |
| 52-Week Low | 2.56 |
| Moving Average 50 Days | 3.1 |
| Moving Average 200 Days | 3.95 |
Statistics
| Average Volume | 3.95M |
| Shares Outstanding | 88.26M |
| % Held by Institutions | 78.66 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | September 14, 2018 |
